Gland FDA Tuesday, January 24, 2023 0.00 Neutral

FDA Approves KETAMINE HYDROCHLORIDE — Gland Pharma Limited

# FDA Approves Gland Pharma's Generic Ketamine Hydrochloride Injection Gland Pharma Limited received FDA approval for its generic ketamine hydrochloride intramuscular injection, expanding the competitive generic market for this widely-used anesthetic and therapeutic agent. The approval is expected to increase price competition and improve patient access to ketamine formulations across hospital and clinical settings.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day